Axilla NOS Intrathoracic NOS Thoracic NOS

Lymphoma NOS Malignant lymphoma NOS Non-Hodgkin's lymphoma NOS

... or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use ...[+++] (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, or other psycho-physiological functions and responses. The disturbances are directly related to the acute pharmacological effects of the substance and resolve with time, with complete recovery, except where tissue damage or other complications have arisen. Complications may include trauma, inhalation of vomitus, delirium, coma, convulsions, and other medical complications. The nature of these complications depends on the pharmacological class of substance and mode of administration. Acute drunkenness in alcoholism Bad trips (drugs) Drunkenness NOS Pathological intoxication Trance and possession disorders in psychoactive substance intoxication Excl.: intoxication meaning poisoning (T36-T50) .1 Harmful use A pattern of psychoactive substance use that is causing damage to health. The damage may be physical (as in cases of hepatitis from the self-administration of injected psychoactive substances) or mental (e.g. episodes of depressive disorder secondary to heavy consumption of alcohol). Psychoactive substance abuse .2 Dependence syndrome A cluster of behavioural, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use than to other activities and obligations, increased tolerance, and sometimes a physical withdrawal state. The dependence syndrome may be present for a specific psychoactive substance (e.g. tobacco, alcohol, or diazepam), for a class of substances (e.g. opioid drugs), or for a wider range of pharmacologically different psychoactive substances. Chronic alcoholism Dipsomania Drug addiction .3 Withdrawal state A group of symptoms of variable clustering and severity occurring on absolute or relative withdrawal of a psychoactive substance after persistent use of that substance. The onset and course of the withdrawal state are time-limited and are related to the type of psychoactive substance and dose being used immediately before cessation o ...

Neuritis or radiculitis:brachial NOS | lumbar NOS | lumbosacral NOS | thoracic NOS | Radiculitis NOS

Pharyngitis (acute):NOS | gangrenous | infective NOS | suppurative | ulcerative | Sore throat (acute) NOS

Modifiers The following fourth-character subdivisions classify morphological changes and are for use with categories N00-N07. Subdivisions .0-.8 should not normally be used unless these have been specifically identified (e.g. by renal biopsy or autopsy). The three-character categories relate to clinical syndromes. Code Title .0 Minor glomerular abnormality Minimal change lesion .1 Focal and segmental glomerular lesions Focal and segmental:hyalinosis | sclerosis | Focal glomerulonephritis .2 Diffuse membranous glomerulonephritis .3 Diffuse mesangial proliferative glomerulonephritis .4 Diffuse endocapillary proliferative glomerulonephritis .5 Diffuse mesangiocapillary glomerulonephritis Membranoproliferative glomerulonephritis, types 1 and 3, or NOS .6 Dense de ...[+++]posit disease Membranoproliferative glomerulonephritis, type 2 .7 Diffuse crescentic glomerulonephritis Extracapillary glomerulonephritis .8 Other Proliferative glomerulonephritis NOS .9 Unspecified | Minimal change lesion | Focal and segmental:hyalinosis | sclerosis | Focal glomerulonephritis | Membranoproliferative glomerulonephritis, types 1 and 3, or NOS | Membranoproliferative glomerulonephritis, type 2 | Extracapillary glomerulonephritis | Proliferative glomerulonephritis NOS

American trypanosomiasis NOS Chagas' disease (chronic) (with):NOS | cardiovascular involvement NEC+ (I98.1*) | myocarditis+ (I41.2*) | Trypanosomiasis NOS, in places where Chagas' disease is prevalent

Infestation (skin) NOS Infestation by mites NOS Skin parasites NOS

Catarrh, enteric or intestinal Colitis | Enteritis | Gastroenteritis | NOS | haemorrhagic | septic | Diarrhoea:NOS | dysenteric | epidemic | Infectious diarrhoeal disease NOS

Growth NOS Neoplasm NOS New growth NOS Tumour NOS

Barbiturates screen, other fluid NEC Benzodiazepines screen, serum/plasma Benzodiazepines screen, urine Benzodiazepines screen, other fluid NEC Cannabis/cannabinoid screen, serum/plasma Cannabis/cannabinoid screen, urine Cannabis/cannabinoid screen, other fluid NEC Cocaine (metabolites) screen, urine Cocaine (metabolites) screen, other fluid NEC Lysergic acid diethylamide screen, serum/plasma Lysergic acid diethylamide screen, urine Morphine screen, serum/plasma Morphine screen, urine Opiate screen, serum/plasma Opiate screen, urine Opiate screen, other fluid NEC Phencyclidine screen, serum/plasma Phencyclidine screen, urine Phenothiazin ...[+++]e screen, serum/plasma Phenothiazine screen, urine Phenothiazine screen, other fluid NEC Salicylate screen, serum/plasma Salicylate screen, urine Salicylate screen, other fluid NEC Tricyclic antidepressants screen, serum/plasma Tricyclic antidepressants screen, urine Tricyclic antidepressants screen, other fluid NEC Drug screen NOS, single drug, serum/plasma Drug screen NOS, single drug, urine Drug screen NOS, single drug, other fluid NEC Drug screen NOS, multiple drugs, serum/plasma Drug screen NOS, multiple drugs, urine Drug screen NOS, multiple drugs, other fluid NEC Acetaldehyde, whole blood Acetaldehyde, serum/plasma Acetone, whole blood Acetone, serum/plasma Acetone, other fluid NEC Alcohol panel NOS, whole blood Alcohol panel NOS, serum/plasma Alcohol panel NOS, other fluid NEC Benzene, qualitative, serum/plasma Benzene, serum/plasma Carbon tetrachloride, whole blood Carbon tetrachloride, serum/plasma Carbon tetrachloride, urine Carbon tetrachloride, other fluid NEC Chloral hydrate, serum/plasma Chloral hydrate, urine ...

Alpha-acetylglucosaminidase, tissue NEC Alpha-fucosidase, WBC Alpha-fucosidase, tissue NEC Alpha-galactosidase, WBC Alpha-galactosidase, tissue NEC Alpha-glucosidase, WBC Alpha-glucosidase, tissue NEC Alpha-iduronidase, serum/plasma Alpha-iduronidase, WBC Alpha-iduronidase, tissue NEC Alpha-mannosidase, WBC Alpha-mannosidase, tissue NEC Alpha-neuraminidase, serum/plasma Alpha-neuraminidase, tissue NEC Arylsulfatase A, serum/plasma Arylsulfatase A, other fluid NEC Arylsulfatase A, WBC Arylsulfatase A, tissue NEC Arylsulfatase B, serum/plasma Arylsulfatase B, other fluid NEC Arylsulfatase B, WBC Arylsulfatase B, tissue NEC Arylsulfatase NO ...[+++]S, serum/plasma Arylsulfatase NOS, other fluid NEC Arylsulfatase NOS, WBC Arylsulfatase NOS, tissue NEC Beta-fructofuranosidase, serum/plasma Beta-fructofuranosidase, WBC Beta-galactosidase, serum/plasma Beta-galactosidase, WBC Beta-galactosidase, tissue NEC Beta-glucocerebrosidase, tissue NEC Beta-glucosidase, WBC Beta-glucosidase, tissue NEC Beta-glucuronidase, WBC Beta-glucuronidase, tissue NEC Galactosylceramidase, tissue NEC Hexosaminidase A, serum/plasma Hexosaminidase B, serum/plasma Hexosaminidase NOS, serum/plasma Hexosaminidase NOS, WBC Hexosaminidase NOS, tissue NEC Uridyl transferase, WBC Uridyl transferase, tissue NEC Lysosomal enzyme NEC, any specimen type 5-Nucleotidase, serum/plasma 5-Nucleotidase, other fluid NEC Acetylcholinesterase, RBC Acid phosphatase, serum/plasma

Annex A - ISG Annual Financial Report Annex B - Common Template for Inter-Institute ISG Funds Transfer Annex C - Treasury Board Terms and Condition for the CIHR ISG Program

Chloral hydrate, other fluid NEC Ethanol, whole blood Ethanol, serum/plasma Ethanol, urine Ethanol, other fluid NEC Ethylene glycol, whole blood Ethylene glycol, serum/plasma Ethylene glycol, other fluid NEC Formaldehyde, whole blood Formaldehyde, serum/plasma Formaldehyde, urine Formaldehyde, other fluid NEC Isopropanol, whole blood Isopropanol, serum/plasma Isopropanol, other fluid NEC Methanol, qualitative, serum/plasma Methanol, qualitative, urine Methanol, serum/plasma Methanol, urine Toluene, serum/plasma Xylene, serum/plasma Volatile assay NEC, any specimen type Carbon monoxide screen, RBC Carbon monoxide, RBC Cyanide, whole blood ...[+++] Cyanide, serum/plasma Cyanide, urine Cyanide, tissue NEC Formate, whole blood Formate, serum/plasma Paraquat, whole blood Paraquat, serum/plasma Pesticides, whole blood Pesticides, serum/plasma Phenol, whole blood Phenol, urine Polychlorinated biphenol, serum/plasma Polychlorinated biphenol, urine Strychnine screen, serum/plasma Strychnine screen, urine Strychnine, serum/plasma Strychnine, urine Toxicology - substance NEC, any specimen type Fetal heart monitoring during active labour, using fetal scalp electrode Counseling, cognition and learning technique NEC Prescription, support activity for assistive/ adaptive device (e.g. supportive stockings, cervical collar, wheelchair etc). Testimony (court), support activity for mental health Testimony (court), support activity for other reason NEC